Evolve BioSystems, UC Davis baby-probiotic spinout, is going global with new $40M financing

Photo of Evolve BioSystems CEO Tim Brown courtesy of Evolve.
Evolve BioSystems is gearing up to take its infant probiotic global and create new products that fight malnutrition, having scored a $40 million Series C financing led by the Bill and Melinda Gates Foundation and Horizon Ventures, Li Ka Shing ...

PE Hub Healthcare Wire delivers private equity and M&A healthcare deal activity, fundraising news, people moves, regulatory updates and much more every Thursday. Subscribe now! It’s FREE.

This content is available for Buyouts subscribers only. Request a free trial to get access for a limited period

If you already have an active Buyouts subscription, please sign in to view this article.